The Model SC9 intraocular lens is designed to treat cataract patients with a single focus spherical optic and rigid structure in order to position the optic to provide intermediate vision.
CORD has filed for the premarket application on the results of 300 patients who’ve received the lens and been monitored for a minimum of one year.
The lens was designed by Stuart Cumming, MD, who previously designed the patented Crystalens, which was approved by the FDA in 2003.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.